BARNES-JEWISH HOSPITAL
WASHINGTON UNIVERSITY SCHOOL OF MEDICINE
About Us
News & Events
Maps & Locations
Contact Us
Google Search
PATIENT AND VISITOR INFORMATION
TREATMENT PROGRAMS
PREVENTION AND SCREENING
RESEARCH
HOW TO HELP
FOR HEALTH PROFESSIONALS
Go back to:
Home
Treatment Programs
Types of Cancer
Clinical Trial Search Results
Share
Head and Neck Cancer
NCI Information
Our Treatment Approach
Clinical Trials
Support Groups
Effects of Treatment
Podcasts
Treatment Team
NEW SEARCH
RETURN TO SEARCH RESULTS
Number:
P2C 8692
Principal Investigator:
Adkins, Douglas
Title:
A T1 Translational Multicenter Randomized Phase II Study of Temsirolimus versus Cetuximab Plus Temsirolimus in Patients with Recurrent / Metastatic Head and Neck Cancer, Who Failed Prior EGFR Based Therapy
Phase:
II
Disease Site:
Multiple Sites
Participating Site(s):
Main Campus
Map and Directions
St. Peters
Map and Directions
West County
Map and Directions
Contact:
800-600-3606 or
info@ccadmin.wustl.edu
Description:
The purpose of this research study is to learn if Temsirolimus (TORISEL®) alone or in combination with Cetuximab (ERBITUX®) can potentially have an effect on head and neck cancers in people who were previously treated with Cetuximab (or another agent in the same class [EGFR inhibitors]) but no longer benefit from this treatment.
More Information:
(Links will take you off this web site)
ClinicalTrials.gov #
Internal Protocol Documents (requires Siteman administrative database password)